Compare FLS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLS | STVN |
|---|---|---|
| Founded | 1790 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.4B |
| IPO Year | N/A | 2021 |
| Metric | FLS | STVN |
|---|---|---|
| Price | $71.69 | $21.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $75.50 | $25.38 |
| AVG Volume (30 Days) | ★ 1.5M | 338.7K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.17% | 0.30% |
| EPS Growth | ★ 69.42 | 19.61 |
| EPS | ★ 3.44 | 0.60 |
| Revenue | ★ $4,687,417,000.00 | $1,373,219,524.00 |
| Revenue This Year | $5.80 | $8.42 |
| Revenue Next Year | $4.04 | $9.52 |
| P/E Ratio | ★ $20.80 | $34.83 |
| Revenue Growth | 3.19 | ★ 6.97 |
| 52 Week Low | $37.34 | $17.81 |
| 52 Week High | $74.63 | $28.00 |
| Indicator | FLS | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 59.81 | 41.77 |
| Support Level | $71.10 | $20.50 |
| Resistance Level | $74.63 | $22.29 |
| Average True Range (ATR) | 1.78 | 1.10 |
| MACD | -0.30 | -0.06 |
| Stochastic Oscillator | 51.01 | 21.08 |
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.